Analog Devices CEO sells 10,000 shares in plan

Analog Devices Chair and CEO Vincent Roche exercised options and sold shares in a planned transaction.

(Very High)

(Very Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Analog Devices Chair and CEO Vincent Roche exercised options and sold shares in a planned transaction. On March 2, he exercised a non-qualified stock option for 10,000 shares at $94.41 per share, then sold 10,000 common shares at $350.00 per share under a Rule 10b5-1 trading plan adopted on May 23, 2025. After these moves, he directly owns 155,688.462 common shares and has an additional 23,515 shares held indirectly through the Vincent Roche 2024 Grantor Retained Annuity Trust.

Insider Trade Summary

Exercise and Sale: 10,000 shares ($2.56M approx. pre-tax spread)

Exercise and Sale 4 txns

Insider ROCHE VINCENT

Role Chair & CEO

Sold 10,000 shs ($3.50M)

Approx. gross sale proceeds $3.50M

Approx. exercise cost $944K

Approx. pre-tax spread $2.56M

Type	Security	Shares	Price	Value
Exercise	Non-Qualified Stock Option (right to buy)	10,000	$94.41	$944K
Exercise	Comm Stock - $.16-2/3 value	10,000	$94.41	$944K
Sale	Comm Stock - $.16-2/3 value	10,000	$350.00	$3.50M
holding	Comm Stock-$.16-2/3 value	--	--	--

Holdings After Transaction: Non-Qualified Stock Option (right to buy) — 34,637 contracts (Direct); Comm Stock - $.16-2/3 value — 155,688.462 shares (Direct); Comm Stock-$.16-2/3 value — 23,515 shares (Indirect, Vincent Roche 2024 Grantor Retained Annuity Trust)

Footnotes (3)

F1. These shares were sold pursuant to a 10b5-1 plan adopted by the Reporting Person on May 23, 2025.
F2. Shares held by the Vincent Roche 2024 Grantor Retained Annuity Trust dated October 3, 2024.
F3. This option is fully vested.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did ADI CEO Vincent Roche report in this Form 4 filing?

Vincent Roche reported exercising stock options and selling shares of Analog Devices. He exercised 10,000 options at $94.41 per share and sold 10,000 common shares at $350.00 per share, all on March 2, as part of a disclosed trading plan.

How many Analog Devices (ADI) shares did the CEO sell in this transaction?

The CEO sold 10,000 Analog Devices common shares. The sale occurred at $350.00 per share and was executed under a pre-arranged Rule 10b5-1 trading plan, indicating the trades were scheduled in advance rather than decided on the trading day.

What stock options did the ADI CEO exercise in this Form 4?

Vincent Roche exercised a non-qualified stock option for 10,000 Analog Devices shares. The exercise price was $94.41 per share, and the filing notes that this option is fully vested, converting the derivative right into directly held common stock before the subsequent sale.

Was the Analog Devices (ADI) CEO’s stock sale pre-planned?

Yes. The filing states the 10,000 shares were sold under a Rule 10b5-1 plan. This plan was adopted by the reporting person on May 23, 2025, meaning the trades were scheduled in advance according to predefined instructions and not timed opportunistically.

How many Analog Devices (ADI) shares does the CEO own after these transactions?

After the reported transactions, Vincent Roche directly owns 155,688.462 Analog Devices common shares. In addition, 23,515 shares are held indirectly through the Vincent Roche 2024 Grantor Retained Annuity Trust, reflecting both direct and trust-related holdings reported in the filing.

What indirect holdings in Analog Devices stock does the ADI CEO report?

The CEO reports 23,515 Analog Devices shares held indirectly. These shares are owned by the Vincent Roche 2024 Grantor Retained Annuity Trust dated October 3, 2024, which is identified in the filing as the entity holding this indirect position on his behalf.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/03/2026 - 04:07 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ROCHE VINCENT

(Last)

(First)

(Middle)

ONE ANALOG WAY

(Street)

WILMINGTON

01887

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
ANALOG DEVICES INC [ ADI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chair & CEO

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Comm Stock - $.16-2/3 value	03/02/2026		M		10,000	A	$94.41	165,688.462	D
Comm Stock - $.16-2/3 value	03/02/2026		S		10,000⁽¹⁾	D	$350	155,688.462	D
Comm Stock-$.16-2/3 value								23,515	I⁽²⁾	Vincent Roche 2024 Grantor Retained Annuity Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Non-Qualified Stock Option (right to buy)	$94.41	03/02/2026		M			10,000	03/15/2021⁽³⁾	03/11/2030	Comm Stock - $.16-2/3 value	10,000	$94.41	34,637	D

Explanation of Responses:

1. These shares were sold pursuant to a 10b5-1 plan adopted by the Reporting Person on May 23, 2025.

2. Shares held by the Vincent Roche 2024 Grantor Retained Annuity Trust dated October 3, 2024.

3. This option is fully vested.

Remarks:

	/s/ Shelly Shaw, General Counsel, by Power of Attorney	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR